ESPR
MODERATEEsperion Therapeutics, Inc.
CIK: 0001434868
Sell
(50% confidence)
Last activity: 3 weeks ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Net Income -$269.11M
Total Cash $144.76M
Total Debt $2.07M
Current Ratio 0.82
Insider Roster (3 total, 3 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Koenig Sheldon L. President and CEO | 0 | 1 | -$177K | 1,470,587 shares $5.40M |
| Looker Benjamin General Counsel | 0 | 2 | -$29K | 384,216 shares $1.11M |
| Halladay Benjamin Chief Financial Officer | 0 | 1 | -$27K | 467,525 shares $1.71M |
Recent Transactions
SELL Looker Benjamin (General Counsel)
1,689 shares @ $2.88
$5K
Jan 20, 2026
Conviction: |
View SEC Filing →
SELL Koenig Sheldon L. (President and CEO)
48,244 shares @ $3.67
$177K
Dec 17, 2025
Conviction: |
View SEC Filing →
SELL Halladay Benjamin (Chief Financial Officer)
7,337 shares @ $3.67
$27K
Dec 17, 2025
Conviction: |
View SEC Filing →
SELL Looker Benjamin (General Counsel)
6,517 shares @ $3.67
$24K
Dec 17, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.